Patents by Inventor Terrill McClanahan

Terrill McClanahan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Canine RANKL and methods for preparing and using the same
    Patent number: 8030450
    Abstract: The present invention provides isolated nucleic acid molecules that encode a substantial part of canine RANKL polypeptide, including the extracellular domains of that polypeptide, the polypeptide and fragments thereof. Vectors and host cells encoding and expressing canine RANKL polypeptide are provided, as well as antibodies that bind to RANKL and that inhibit RANKL activity. Also provided are methods of treating an animal to inhibit or treat the loss of bone minerals.
    Type: Grant
    Filed: November 6, 2008
    Date of Patent: October 4, 2011
    Assignee: Intervet Inc.
    Inventors: Jeanine D. Mattson, Terrill McClanahan
  • CANINE RANKL AND METHODS FOR PREPARING AND USING THE SAME
    Publication number: 20090148456
    Abstract: The present invention provides isolated nucleic acid molecules that encode a substantial part of canine RANKL polypeptide, including the extracellular domains of that polypeptide, the polypeptide and fragments thereof. Vectors and host cells encoding and expressing canine RANKL polypeptide are provided, as well as antibodies that bind to RANKL and that inhibit RANKL activity. Also provided are methods of treating an animal to inhibit or treat the loss of bone minerals.
    Type: Application
    Filed: November 6, 2008
    Publication date: June 11, 2009
    Inventors: Jeanine D. Mattson, Terrill McClanahan
  • Canine RANKL and methods for preparing and using the same
    Patent number: 7462700
    Abstract: The present invention provides isolated nucleic acid molecules that encode a substantial part of canine RANKL polypeptide, including the extracellular domains of that polypeptide, the polypeptide and fragments thereof. Vectors and host cells encoding and expressing canine RANKL polypeptide are provided, as well as antibodies that bind to RANKL and that inhibit RANKL activity. Also provided are methods of treating an animal to inhibit or treat the loss of bone minerals.
    Type: Grant
    Filed: December 10, 2003
    Date of Patent: December 9, 2008
    Assignee: Schering-Plough Animal Health Corporation
    Inventors: Jeanine D. Mattson, Terrill McClanahan
  • USES OF IL-23 AGONISTS AND ANTAGONISTS; RELATED REAGENTS
    Publication number: 20080057058
    Abstract: Provided are methods of treatment for tumors. In particular, methods are provided for modulating activity of a cytokine molecule and its receptor.
    Type: Application
    Filed: August 31, 2007
    Publication date: March 6, 2008
    Applicant: Schering Corporation
    Inventors: Martin Oft, Terrill McClanahan
  • TUMOR ASSOCIATION OF MDL-1 AND METHODS
    Publication number: 20070237772
    Abstract: The invention provides methods for detecting, diagnosing, localizing and imaging tumors. The invention also relates to methods for detecting, diagnosing, localizing, imaging and treating cancer.
    Type: Application
    Filed: January 19, 2007
    Publication date: October 11, 2007
    Applicant: Schering Corporation
    Inventors: TERRILL MCCLANAHAN, Joseph Phillips
  • Use of cytokine expression to predict skin inflammation; methods of treatment
    Publication number: 20070098727
    Abstract: Provided are methods for diagnosing the propensity of a subject to develop skin inflammation, in particular, psoriasis. Also provided are methods of treatment with antagonists of IL-17, IL-19, and/or IL-23.
    Type: Application
    Filed: December 8, 2006
    Publication date: May 3, 2007
    Inventors: Robert Kastelein, Terrill McClanahan, Erin Murphy, Jason Chan
  • Canine rankl and methods for preparing and using the same
    Publication number: 20060154858
    Abstract: The present invention provides isolated nucleic acid molecules that encode a substantial part of canine RANKL polypeptide, including the extracellular domains of that polypeptide, the polypeptide and fragments thereof. Vectors and host cells encoding and expressing canine RANKL polypeptide are provided, as well as antibodies that bind to RANKL and that inhibit RANKL activity. Also provided are methods of treating an animal to inhibit or treat the loss of bone minerals.
    Type: Application
    Filed: December 10, 2003
    Publication date: July 13, 2006
    Inventors: Jeanine Mattson, Terrill McClanahan
  • Tumor association of MDL-1 and methods
    Publication number: 20060099144
    Abstract: The invention provides methods for detecting, diagnosing, localizing and imaging tumors. The invention also relates to methods for detecting, diagnosing, localizing, imaging and treating cancer.
    Type: Application
    Filed: November 7, 2005
    Publication date: May 11, 2006
    Applicant: Schering Corporation
    Inventors: Terrill McClanahan, Joseph Phillips
  • Antibodies that specifically bind to FDF03
    Publication number: 20050287582
    Abstract: Nucleic acids encoding various monocyte cell proteins from a primate, reagents related thereto, including specific antibodies, and purified proteins are described. Methods of using said reagents and related diagnostic kits are also provided.
    Type: Application
    Filed: August 4, 2005
    Publication date: December 29, 2005
    Applicant: Schering Corporation
    Inventors: Gosse Adema, Linde Meyaard, Daniel Gorman, Terrill McClanahan, Sandra Zurawski, Gerard Zurawski, Lewis Lanier, Joseph Phillips
  • Use of cytokine expression to predict skin inflammation; methods of treatment
    Publication number: 20050287593
    Abstract: Provided are methods for diagnosing the propensity of a subject to develop skin inflammation, in particular, psoriasis. Also provided are methods of treatment with antagonists of IL-17, IL-19, and/or IL-23.
    Type: Application
    Filed: September 2, 2005
    Publication date: December 29, 2005
    Applicant: Schering Corporation
    Inventors: Robert Kastelein, Terrill McClanahan, Erin Murphy, Jason Chan
  • Use of IL-17 expression to predict skin inflammation; methods of treatment
    Publication number: 20050244874
    Abstract: Provided are methods for diagnosing the propensity of a subject to develop skin inflammation, in particular, psoriasis. Also provided are methods of treatment with antagonists of IL-17 and/or IL-23.
    Type: Application
    Filed: May 2, 2005
    Publication date: November 3, 2005
    Applicant: Schering Corporation
    Inventors: Robert Kastelein, Terrill McClanahan, Erin Murphy
  • Methods of modulating cytokine activity; related reagents
    Publication number: 20050214296
    Abstract: Provided are methods of modulating cytokine activity, e.g., for the purpose of treating immune and inflammatory disorders. Also provided are methods of administering agonists or antagonists of IL-27 and IL-27 receptor.
    Type: Application
    Filed: February 15, 2005
    Publication date: September 29, 2005
    Applicant: Schering Corporation
    Inventors: Robert Kastelein, Terrill McClanahan, Stefan Pflanz
  • Mammalian genes; related reagents and methods
    Publication number: 20050186620
    Abstract: Nucleic acids encoding mammalian, e.g., primate or rodent, genes, purified proteins and fragments thereof. Antibodies, both polyclonal and monoclonal, are also provided. Methods of using the compositions for both diagnostic and therapeutic utilities are provided.
    Type: Application
    Filed: March 25, 2005
    Publication date: August 25, 2005
    Applicant: Schering Corporation
    Inventors: Christi Parham, Daniel Gorman, Hirokazu Kurata, Naoko Arai, Theodore Sana, Jeanine Mattson, Erin Murphy, Chetan Savkoor, Jeffery Grein, Kathleen Smith, Terrill McClanahan
  • Isolated mammalian monocyte cell genes; related reagents
    Publication number: 20050059808
    Abstract: Nucleic acids encoding various monocyte cell proteins from a primate, reagents related thereto, including specific antibodies, and purified proteins are described. Methods of using said reagents and related diagnostic kits are also provided.
    Type: Application
    Filed: February 11, 2004
    Publication date: March 17, 2005
    Inventors: Gosse Adema, Linde Meyaard, Daniel Gorman, Terrill McClanahan, Sandra Zurawski, Gerard Zurawski, Lewis Lanier, Joseph Phillips